Miller Eric A, Woosley John, Martin Christopher F, Sandler Robert S
Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, USA.
Cancer. 2004 Sep 1;101(5):1065-71. doi: 10.1002/cncr.20478.
Better recovery of lymph nodes from colorectal carcinoma resection specimens has been shown to be associated with higher survival rates for patients with TNM Stage II and Stage III tumors. It is possible that inadequate lymph node recovery and/or assessment could contribute to disparities in survival, with particular variation according to hospital volume.
Data from a population-based study that involved 33 counties in North Carolina and was conducted between April 1997 and April 2000 were available for the examination of variations in lymph node recovery and detection of positive lymph nodes according to self-reported demographic characteristics and hospital volume. The study comprised 324 patients with T2-T3N0-N1M0 colon adenocarcinoma. Logistic regression was used to determine odds ratios (ORs) associated with the recovery of fewer than seven lymph nodes and ORs associated with the detection of a positive lymph node according to hospital volume and patient characteristics.
Low-volume hospitals were more likely to recover < 7 lymph nodes compared with high- and medium-volume hospitals (low-volume vs. high-volume: adjusted OR, 1.9; 95% confidence interval [CI], 0.8-4.6; low-volume vs. medium-volume: adjusted OR, 1.7; 95% CI, 0.7-4.5) and less likely to detect positive lymph nodes. After controlling for tumor characteristics, low-volume hospitals were less than one-half as likely to detect a positive lymph node (low-volume vs. high-volume: adjusted OR, 0.3; 95% CI, 0.1-0.8; low-volume vs. medium-volume: adjusted OR, 0.4; 95% CI, 0.1-1.2).
The current study suggests that patients at low-volume hospitals may have their tumors pathologically understaged more frequently compared with patients at high- and medium-volume hospitals.
已表明,从结直肠癌切除标本中更好地回收淋巴结与TNM II期和III期肿瘤患者的较高生存率相关。淋巴结回收和/或评估不足可能导致生存差异,尤其是根据医院规模存在差异。
可获得一项基于人群的研究数据,该研究于1997年4月至2000年4月在北卡罗来纳州的33个县进行,用于根据自我报告的人口统计学特征和医院规模检查淋巴结回收和阳性淋巴结检测的差异。该研究包括324例T2-T3N0-N1M0结肠腺癌患者。采用逻辑回归确定与回收少于7个淋巴结相关的比值比(OR)以及根据医院规模和患者特征与检测到阳性淋巴结相关的OR。
与高容量和中等容量医院相比,低容量医院更有可能回收<7个淋巴结(低容量与高容量:调整后OR,1.9;95%置信区间[CI],0.8-4.6;低容量与中等容量:调整后OR,1.7;95%CI,0.7-4.5),且检测到阳性淋巴结的可能性较小。在控制肿瘤特征后,低容量医院检测到阳性淋巴结的可能性不到高容量医院的一半(低容量与高容量:调整后OR,0.3;95%CI,0.1-0.8;低容量与中等容量:调整后OR,0.4;95%CI,0.1-1.2)。
当前研究表明,与高容量和中等容量医院的患者相比,低容量医院的患者肿瘤病理分期错误的情况可能更频繁。